Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

John Carroll to Foramen Ovale, Patent

This is a "connection" page, showing publications John Carroll has written about Foramen Ovale, Patent.

 
Connection Strength
  
 
 
10.940
  
  1. Orjuela KD, Leppert MH, Carroll JD. Navigating the Gray: The Complex Story of PFO Closure Utilization. Circ Cardiovasc Qual Outcomes. 2024 01; 17(1):e010581.
    View in: PubMed
    Score: 0.869
  2. Won H, Carroll JD. Comparative effectiveness research applied to medical devices: Which PFO closure device is the best? Catheter Cardiovasc Interv. 2020 02 15; 95(3):373-374.
    View in: PubMed
    Score: 0.664
  3. Carroll AM, Carroll JD. Device Closure of Patent Foramen Ovale for Cryptogenic Stroke: Patient Selection and Outcomes According to New Randomized Trials. Curr Cardiol Rep. 2019 04 22; 21(6):48.
    View in: PubMed
    Score: 0.627
  4. Carroll JD. A Positive Bubble Test Post-Patent Foramen Ovale Closure: Was Satisfaction-of-Search to Blame? JACC Cardiovasc Interv. 2018 06 11; 11(11):1105-1107.
    View in: PubMed
    Score: 0.591
  5. Wiktor DM, Carroll JD. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke. Circ Cardiovasc Interv. 2018 03; 11(3):e004152.
    View in: PubMed
    Score: 0.579
  6. Fenster BE, Freeman AM, Silveira L, Buckner JK, Curran-Everett D, Carroll JD. Exercise treadmill saline contrast echocardiography for the detection of patent foramen ovale in hypoxia. Int J Cardiovasc Imaging. 2015 Dec; 31(8):1537-43.
    View in: PubMed
    Score: 0.484
  7. Carroll JD, Fuller CJ. RoPE: a safety line but tangles remain. Neurology. 2014 Jul 15; 83(3):204-5.
    View in: PubMed
    Score: 0.448
  8. Fenster BE, Curran-Everett D, Freeman AM, Weinberger HD, Kern Buckner J, Carroll JD. Saline contrast echocardiography for the detection of patent foramen ovale in hypoxia: a validation study using intracardiac echocardiography. Echocardiography. 2014 Apr; 31(4):420-7.
    View in: PubMed
    Score: 0.428
  9. Dattilo PB, Kim MS, Carroll JD. Patent foramen ovale. Cardiol Clin. 2013 Aug; 31(3):401-15.
    View in: PubMed
    Score: 0.422
  10. Fenster BE, Nguyen BH, Buckner JK, Freeman AM, Carroll JD. Effectiveness of percutaneous closure of patent foramen ovale for hypoxemia. Am J Cardiol. 2013 Oct 15; 112(8):1258-62.
    View in: PubMed
    Score: 0.421
  11. Carroll JD, Saver JL. Patent foramen ovale and cryptogenic stroke. N Engl J Med. 2013 07 04; 369(1):91-2.
    View in: PubMed
    Score: 0.419
  12. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013 Mar 21; 368(12):1092-100.
    View in: PubMed
    Score: 0.411
  13. Carroll JD. Challenges in understanding rare but serious problems associated with septal occluders. Catheter Cardiovasc Interv. 2012 Sep 01; 80(3):503.
    View in: PubMed
    Score: 0.396
  14. Carroll JD. Double standards in the world of ASD and PFO management: closure for paradoxical embolism. Catheter Cardiovasc Interv. 2009 Dec 01; 74(7):1070-1.
    View in: PubMed
    Score: 0.327
  15. Carroll JD, Carroll EP. Is patent foramen ovale closure indicated for migraine?: PFO closure is not indicated for migraine: "Don't shoot first, ask questions later". Circ Cardiovasc Interv. 2009 Oct; 2(5):475-81.
    View in: PubMed
    Score: 0.323
  16. Carroll JD. Image guidance for PFO closure: is transnasal TEE an option? Catheter Cardiovasc Interv. 2008 Oct 01; 72(4):542-3.
    View in: PubMed
    Score: 0.302
  17. Carroll JD. Migraine Intervention With STARFlex Technology trial: a controversial trial of migraine and patent foramen ovale closure. Circulation. 2008 Mar 18; 117(11):1358-60.
    View in: PubMed
    Score: 0.290
  18. Carroll JD. PFO closure in 2008: See through a glass, darkly. Catheter Cardiovasc Interv. 2008 Feb 15; 71(3):388-9.
    View in: PubMed
    Score: 0.289
  19. Carroll JD. PFO anatomy: 3D characterization and device performance. Catheter Cardiovasc Interv. 2008 Feb 01; 71(2):229-30.
    View in: PubMed
    Score: 0.288
  20. Carroll J, Onorato E, Saver J, Smalling R, Thaler D, Tobis J. Data that may shed some light on: "arguments against insisting on randomized trials for PFO closure". Catheter Cardiovasc Interv. 2007 Nov 15; 70(6):904-5; author reply 906.
    View in: PubMed
    Score: 0.284
  21. Mas JL, Saver JL, Kasner SE, Nelson J, Carroll JD, Chatellier G, Derumeaux G, Furlan AJ, Herrmann HC, J?ni P, Kim JS, Koethe B, Lee PH, Lefebvre B, Mattle HP, Meier B, Reisman M, Smalling RW, Sondergaard L, Song JK, Thaler DE, Kent DM. Association of Atrial Septal Aneurysm and Shunt Size With Stroke Recurrence and Benefit From Patent Foramen Ovale Closure. JAMA Neurol. 2022 11 01; 79(11):1175-1179.
    View in: PubMed
    Score: 0.200
  22. Kent DM, Saver JL, Kasner SE, Nelson J, Carroll JD, Chatellier G, Derumeaux G, Furlan AJ, Herrmann HC, J?ni P, Kim JS, Koethe B, Lee PH, Lefebvre B, Mattle HP, Meier B, Reisman M, Smalling RW, Soendergaard L, Song JK, Mas JL, Thaler DE. Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke. JAMA. 2021 12 14; 326(22):2277-2286.
    View in: PubMed
    Score: 0.188
  23. Pristipino C, Germonpr? P, Toni D, Sievert H, Meier B, D'Ascenzo F, Berti S, Onorato EM, Bedogni F, Mas JL, Scacciatella P, Hildick-Smith D, Gaita F, Kyrle PA, Thomson J, Derumeaux G, Sibbing D, Chessa M, Hornung M, Zamorano J, Dudek D, D'Ascenzo F, Omed? P, Ballocca F, Barbero U, Giordana F, Gili S, Iannaccone M, Akagi T, Anzola G, Carroll J, Dalvi B, Angelis C, Junbo G, Kasner SE, Michel-Behnke I, Musumeci G, S?ndergaard L, Tarantini G, Biondi-Zoccai GGL, Capodanno D, Valgimigli M, Byrne R, Kunadian V. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions. Eur Heart J. 2021 04 21; 42(16):1545-1553.
    View in: PubMed
    Score: 0.180
  24. Kent DM, Saver JL, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Smalling RW, J?ni P, Mattle HP, Meier B, Thaler DE. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials. Stroke. 2020 10; 51(10):3119-3123.
    View in: PubMed
    Score: 0.173
  25. Shah AH, Kass M, Carroll J. Is Hypoxia in Standing Position Mandatory in Defining Platypnea-Orthodeoxia Syndrome? JACC Cardiovasc Interv. 2020 09 28; 13(18):e165-e166.
    View in: PubMed
    Score: 0.171
  26. Elgendy AY, Saver JL, Amin Z, Boudoulas KD, Carroll JD, Elgendy IY, Grunwald IQ, Gertz ZM, Hijazi ZM, Horlick EM, Kasner SE, Kent DM, Kumar P, Kavinsky CJ, Liebeskind DS, Lutsep H, Mojadidi MK, Mess? SR, Mas JL, Mattle HP, Meier B, Mahmoud A, Mahmoud AN, Nietlispach F, Patel NK, Rhodes JF, Reisman M, Sommer RJ, Sievert H, S?ndergaard L, Zaman MO, Thaler D, Tobis JM. Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. JAMA Neurol. 2020 07 01; 77(7):878-886.
    View in: PubMed
    Score: 0.170
  27. Mess? SR, Gronseth GS, Kent DM, Kizer JR, Homma S, Rosterman L, Carroll JD, Ishida K, Sangha N, Kasner SE. Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology. Neurology. 2020 05 19; 94(20):876-885.
    View in: PubMed
    Score: 0.168
  28. Horlick E, Kavinsky CJ, Amin Z, Boudoulas KD, Carroll JD, Hijazi ZM, Leifer D, Lutsep HL, Rhodes JF, Tobis JM. SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Catheter Cardiovasc Interv. 2019 04 01; 93(5):859-874.
    View in: PubMed
    Score: 0.156
  29. Leppert MH, Poisson SN, Carroll JD, Thaler DE, Kim CH, Orjuela KD, Ho PM, Burke JF, Campbell JD. Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention. Stroke. 2018 06; 49(6):1443-1450.
    View in: PubMed
    Score: 0.147
  30. Tirschwell DL, Turner M, Thaler D, Choulerton J, Marks D, Carroll J, MacDonald L, Smalling RW, Koullick M, Gu NY, Saver JL. Cost-effectiveness of percutaneous patent foramen ovale closure as secondary stroke prevention. J Med Econ. 2018 Jul; 21(7):656-665.
    View in: PubMed
    Score: 0.146
  31. Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med. 2017 09 14; 377(11):1022-1032.
    View in: PubMed
    Score: 0.140
  32. Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, J?ni P, Mattle HP, Meier B, Thaler DE. Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials. J Am Coll Cardiol. 2016 Mar 01; 67(8):907-917.
    View in: PubMed
    Score: 0.126
  33. Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, Trelle S, Windecker S, Meier B, J?ni P. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J. 2015 Jan 07; 36(2):120-8.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)